What are Antimicrobial peptide drugs?

Antimicrobial peptide drugs are pharmacologic agents that share a common mechanism (typically targeting Bacterial cell membranes). 1 are currently marketed, with 4 more in clinical development.

What are the marketed Antimicrobial peptide drugs?

Marketed Antimicrobial peptide drugs include PNA.

Antimicrobial peptide

1 marketed 3 in Phase 3 1 in Phase 2

This page covers all Antimicrobial peptide drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Bacterial cell membranes, Bacterial cell membrane (lipopolysaccharides and lipoteichoic acids), Bacterial cell membrane.

Targets

Bacterial cell membranes · Bacterial cell membrane (lipopolysaccharides and lipoteichoic acids) · Bacterial cell membrane

Marketed (1)

PNA · Guangzhou Yipinhong Pharmaceutical CO.,LTD · Infectious diseases
PNA is a type of antimicrobial peptide that works by disrupting bacterial cell membranes.

Phase 3 pipeline (3)

CLS001 (Omiganan) · Maruho Co., Ltd. · Infectious Disease / Dermatology
Omiganan is an antimicrobial peptide that disrupts bacterial cell membranes by binding to lipopolysaccharides and lipoteichoic acids, leading to bacterial cell death.
Topical pexiganan cream 0.8% · Dipexium Pharmaceuticals, Inc. · Infectious Disease / Dermatology
Pexiganan is an antimicrobial peptide that disrupts bacterial cell membranes, killing a broad spectrum of bacteria including antibiotic-resistant strains.
MSI-78 · Abeona Therapeutics, Inc · Infectious Disease
MSI-78 is an antimicrobial peptide that disrupts bacterial cell membranes to treat infections caused by multidrug-resistant pathogens.

Phase 2 pipeline (1)

High dose rhCC10 · Tufts Medical Center · Respiratory
High dose rhCC10 is a recombinant human tracheobronchial antimicrobial peptide that has antimicrobial properties.